Related Experiment Video
Updated: Jul 28, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
[Primary intracranial melanoma: a case report]
1Department of Neurosurgery, Kitasato Institute Medical Center Hospital.
Abstract:
A rare case of primary intracranial melanoma is presented in a 34-year-old man with initial symptoms of persistent headache. In magnetic resonance imaging(MRI), this case had all the characteristic findings of intracranial melanoma which had been reported previously. In 123I-iodoamphetamine-single photon emission CT (123I-IMP-SPECT), abnormal accumulation of 123I-IMP was recognized in early and late phase imaging, which was very specific to the lesion. This is the first report of 123I-IMP-SPECT performed on a primary intracranial melanoma. Tumor mass originated from pia mater was surgically resected, but the dissemination of tumor cells was recognized macroscopically. Pathological examination of the specimen showed very little malignant changes of melanoma cells, which was in contrast to the previous reports. Although, no standard chemotherapy of the primary intracranial melanoma has been established, DAV therapy to the dissemination of tumor cells into the subarachnoid space, and intravenous administration of interferon-beta were performed in this case. Methods of differential diagnosis and treatments of primary intracranial melanoma are reviewed and discussed.
Insights
This study presents a rare case of primary intracranial melanoma in a 34-year-old man. 123I-IMP-SPECT imaging identified abnormal accumulation, offering a specific diagnostic tool for this rare brain tumor.
Area of Science:
- Neuro-oncology
- Diagnostic Imaging
Background:
- Primary intracranial melanoma is a rare brain tumor.
- Early symptoms can include persistent headaches.
Observation:
- A 34-year-old male presented with symptoms suggestive of intracranial melanoma.
- Magnetic resonance imaging (MRI) showed characteristic findings.
- 123I-iodoamphetamine-single photon emission computed tomography (123I-IMP-SPECT) revealed specific abnormal tracer accumulation.
Findings:
- This is the first report detailing 123I-IMP-SPECT in a primary intracranial melanoma case.
- Tumor resection was performed, but macroscopic dissemination was noted.
- Pathological examination showed less malignant changes than typically reported.
Implications:
- 123I-IMP-SPECT may serve as a specific diagnostic modality for primary intracranial melanoma.
- Treatment strategies, including DAV therapy and interferon-beta, were employed.
- Further research is needed for established treatment protocols for this rare condition.

